Understanding the Role of Rebates in Prescription Drug Pricing

During this briefing, panelists discussed the mechanisms of pharmaceutical rebates in Medicare Part D and commercial insurance. The audience left with more information on the origins of the rebate system, the actors responsible for negotiation, and the impact of rebates on prescription drug prices.

Public Briefing

During this briefing, panelists discussed the mechanisms of pharmaceutical rebates in Medicare Part D and commercial insurance. The audience left with more information on the origins of the rebate system, the actors responsible for negotiation, and the impact of rebates on prescription drug prices.

Panelists

  • Gerard Anderson, Ph.D., professor, Johns Hopkins University Bloomberg School Public Health
  • Lida Etemad, PharmD, M.S., vice president, Pharmacy Management Strategies
  • Lance Grady, vice president, Avalere Health
  • Jack Hoagley, Ph.D., M.A., research professor emeritus, Georgetown University Health Policy Institute
  • Ross Margulies, J.D., MPH, associate, Foley Hoag LLP